A study co-led by investigators at the UCLA Health Jonsson Comprehensive Cancer Center shows promising results for a drug that treats patients with a rare genetic type of early-stage lung cancer, researchers said Sunday. The study, funded by Eli Lilly and Company, indicated that the targeted cancer drug selpercatinib can significantly reduce the risk of […]
